Clinical Trial

A Clinical Study GK01 Cell Injection in Subjects With Advanced Lung Cancer

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
A Single-Arm, Open-Label Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of GK01 Cell Injection in Participants with Advanced Lung Cancer
Trial Details
NCT Number NCT07673419
Lead Sponsor Beijing Geekgene Technology Co., LTD
Conditions Advanced Lung Cancer
Enrollment 10 participants
Start Date 2026-07
Primary Completion 2028-06 (estimated)
Study Completion 2028-07 (estimated)
Updated on ClinicalTrials.gov 2026-06-29